.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Teva
Moodys
Deloitte
Citi
Harvard Business School
Dow
McKinsey
Express Scripts
UBS

Generated: November 20, 2017

DrugPatentWatch Database Preview

ONDANSETRON HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Ondansetron Hydrochloride, and what generic Ondansetron Hydrochloride alternatives are available?

Ondansetron Hydrochloride is a drug marketed by Chartwell Molecules, Mylan Labs Ltd, Apotex, Taro, Qilu Pharm Co Ltd, Pliva Hrvatska Doo, Lannett, Sandoz, Emcure Pharms, Gland Pharma Ltd, Sandoz Inc, Mylan, Glenmark Generics, Luitpold, Aurobindo Pharma, Hospira, Silarx, Hikma Intl Pharms, Accord Hlthcare, Sun Pharm Inds (in), Natco Pharma Ltd, Teva, West-ward Pharms Int, Ipca Labs Ltd, Apotex Inc, Fresenius Kabi Usa, Wockhardt, Sagent Pharms, Hikma Farmaceutica, Amneal Pharms, Dr Reddys Labs Ltd, Baxter Hlthcare Corp, Aurobindo Pharma Ltd, Taro Pharms Ireland, Emcure Pharms Ltd, and Sun Pharm Inds Ltd. and is included in sixty-eight NDAs.

The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.

Pharmacology for ONDANSETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION202599-001Dec 21, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds (in)
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL077050-001Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL078539-003Jul 31, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
ondansetron hydrochloride
INJECTABLE;INJECTION202253-001Jul 19, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
SOLUTION;ORAL076960-001Dec 26, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION077577-001Dec 26, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Teva
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL076252-001Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Ipca Labs Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL203761-001Jan 23, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds (in)
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION077172-001Dec 26, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION078180-001Mar 26, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Covington
Mallinckrodt
Cerilliant
Fish and Richardson
Dow
Teva
Citi
Argus Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot